SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending as its community fervently debates and anticipates a potential S&P 500 inclusion, which has sharply divided sentiment between expectations of a significant rally and fears of a decline, amidst broader market volatility.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as news circulates about the departure of a key FDA official, which the community believes removes a significant hurdle and could accelerate the approval path for their Duchenne Muscular Dystrophy (DMD) therapy, Deramiocel; this development, combined with upcoming Phase 3 data presentations, is intensifying short squeeze and buyout speculation.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is surging as a key FDA official's departure and reports of a less invasive trial design for its Huntington's gene therapy ignite community hopes for accelerated approval, triggering a significant short squeeze after a week of regulatory setbacks.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings (LITE) is trending amid its S&P 500 inclusion and a significant strategic investment from NVIDIA, solidifying its critical position in AI infrastructure expansion. The community is actively discussing whether its high valuation is justified by its role in supplying advanced optical components, particularly in light of industry perspectives on optical versus copper solutions for data center connectivity.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings Co. (VRT) is a major talking point among investors after its announcement to join the S&P 500 index on 3/23, leading to widespread discussion around anticipated 'inclusion play' gains and the implications of forced buying by index funds.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as CEO Doug Ingram's upcoming retirement, prompted by a personal family health challenge, sparks community discussion about potential M&A and a fresh leadership direction. This, coupled with optimism over a potentially evolving FDA regulatory landscape and anticipation for new siRNA pipeline data, fuels talks of the company's significant undervaluation and short-squeeze potential.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending as its fortified balance sheet, recent defense contract wins, U.S. Army qualification, and a new CEO compensation plan tied to aggressive valuation milestones spark intense community debate, balancing optimism for its critical role in aerospace and defense against concerns over institutional exits, high short interest, and potential dilution.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

With upcoming clinical data readouts and potential international approvals for its personalized TIL therapy, Iovance Biotherapeutics is showing exceptional relative strength in a weak market, sparking community speculation of a significant short squeeze and potential buyout.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

NVIDIA's substantial investment and strategic partnership for optical interconnects has put Coherent at the forefront of the AI infrastructure conversation, with investors also discussing its recent S&P 500 inclusion as a key sector player.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is surging as escalating conflict with Iran significantly disrupts oil traffic through the vital Strait of Hormuz, driving the biggest weekly crude gains in decades. The community is actively debating whether this is a genuine physical supply squeeze or fear-driven, with many expecting oil to climb well past $100 as regional producers face storage limits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The filings include five applications for EL-22 and five corresponding applications for EL-32.</li><li>Two applications for the promotion of muscle growth and increase muscle yield per animal, the company said.</li><li>Additional filings target reductions in gaseous emissions and improved animal health.</li></ul>Shares of PMGC Holdings Inc. (ELAB) shot up 12% in pre-market trading on Thursday after the company announced that its unit, NorthStrive Biosciences, filed 10 new U.S. patent applications aimed at expanding its proprietary EL-22 and EL-32 technologies into animal health and agriculture markets.<h2 class="st-heading-2">Patent Expansion Boost For Company</h2>The filings include five applications for EL-22 and five corresponding applications for EL-32, spanning livestock, aquaculture, and poultry sectors. Two applications cover the use of the technologies as non-feed additive supplements to promote muscle growth and increase muscle yield per animal.Additional filings target reductions in gaseous emissions and improved animal health, including mitigation of ruminal tympany, a serious digestive disorder.In aquaculture, the patents address muscle growth, improved production efficiency, and reduced emissions to combat eutrophication, which can lead to low oxygen levels in water bodies. The final set of applications focuses on enhancing muscle development and yield in poultry within standard growth cycles.<h2 class="st-heading-2">Exclusive Licensing Deal With Modulant</h2>This comes just over a week after NorthStrive Biosciences signed an exclusive license with Modulant Biosciences to give the company a worldwide, royalty-bearing license, excluding South Korea, to develop and commercialize products using EL-22 and EL-32 assets. Modulant will handle all development, manufacturing, regulatory, and commercialization activities under the deal.EL-22 helps activate the body’s immune system to block myostatin, a protein that limits muscle growth. When combined with existing GLP-1 weight-loss treatments, this approach could help obese patients lose fat while maintaining healthy muscle mass, the company said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/ELAB">ELAB</a> on Stocktwits flipped to ‘bullish’ from ‘bearish’ a day earlier.<img src="https://news.stocktwits-cdn.com/ELAB_jpg_f7486e001d.webp" alt="ELAB.jpg">One user hoped to see “higher prices soon.”<stembedurl>https://stocktwits.com/NsaneStocks/message/645309441</stembedurl>Another user expects the stock to hit $3 if it breaks past the $1.56 resistance.<stembedurl>https://stocktwits.com/etrade/message/645306771</stembedurl>The stock has been under heavy selling pressure, slumping nearly 77% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/cvna-stock-slumps-2026-guidance-concerns-analyst-target-cut/cZRjztsR4Db">CVNA Stock Slumps 10% Pre-Market: Wall Street Questions 2026 Visibility, Retail Flags ‘Deterioration’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

This Heavily Sold Nano-Cap Skincare Stock Jumped 12% Pre-Market – What Happened?

PMGC's unit, NorthStrive Biosciences, filed 10 new U.S. patent applications for EL-22 and EL-32 technologies in the animal health and agriculture markets.

Equity

<ul class="summary-bullets"><li>The company stated that Modulant has obtained a worldwide license for the two NorthStrive assets, excluding the Republic of Korea.</li><li>PMGC said that NorthStrive’s EL-22 and EL-32 assets are based on proprietary intellectual property targeting the myostatin and activin-A pathways.</li><li>These pathways are key biological regulators of muscle development, strength, and metabolic efficiency, according to the company.</li></ul>PMGC Holdings Inc. (ELAB) shares soared nearly 45% in Wednesday’s pre-market trade after the company’s wholly-owned subsidiary, NorthStrive Biosciences, signed an exclusive license agreement with Modulant Biosciences.PMGC stated that the license grants Modulant an exclusive, royalty-bearing, sublicensable license to develop, manufacture, and commercialize products using NorthStrive’s EL-22 and EL-32 assets.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/ELAB">PMGC Holdings</a> trended in the ‘bullish’ territory at the time of writing, with message volumes at ‘high’ levels.<h2 class="st-heading-2">What Is The Deal About?</h2>PMGC stated that Modulant has obtained a worldwide license for the two NorthStrive assets, excluding the Republic of Korea.The company said that NorthStrive’s EL-22 and EL-32 assets are based on proprietary intellectual property targeting the myostatin and activin-A pathways. These pathways are key biological regulators of muscle development, strength, and metabolic efficiency.PMGC added that these pathways are increasingly being considered as important targets for several applications in animal health and nutrition. This includes productivity of the livestock, feed efficiency, and companion animal muscle health and aging.The company noted that while the license grants Modulant access to EL-22 and EL-32 assets, EL-32 is responsible for all development, manufacturing, regulatory, and commercialization activities.<h2 class="st-heading-2">What Does NorthStrive Do?</h2>NorthStrive is a California-based biopharmaceutical company that is engaged in the development and acquisition of aesthetic medicines.The company stated that its lead asset, EL-22, is designed to preserve muscle during weight-loss treatments, including GLP-1 receptor agonists.<a href="https://stocktwits.com/symbol/ELAB">ELAB stock</a> is down 71% year-to-date and 99% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/qxo-stock-rising-after-agreement-to-acquire-kodiak/cZb6QV0R4qV">QXO Stock Is Soaring Pre-Market Today — What Is Fueling The Surge?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

ELAB Stock Soars Pre-Market As PMGC Subsidiary NorthStrive Signs Exclusive License Agreement With Modulant Biosciences

PMGC stated that the license grants Modulant an exclusive, royalty-bearing, sublicensable license to develop, manufacture, and commercialize products using NorthStrive’s EL-22 and EL-32 assets.

<ul class="summary-bullets"><li>Investors turned cautious ahead of key U.S. jobs data and a potential court ruling on President Donald Trump’s global tariffs expected Friday.&nbsp;</li><li>Retail traders, however, stayed bullish on SPY and QQQ on Stocktwits.</li></ul>U.S. stock futures were lower early Thursday, following a pullback in major indexes. President&nbsp;Donald Trump’s policy comments triggered a late selloff, with defense, financial, and energy stocks under pressure.Investors are also cautious ahead of the big jobs data and the potential US court&nbsp;ruling on Trump’s global tariffs due on Friday.&nbsp;As of 3:00 a.m. ET on Thursday, Nasdaq 100 futures were down 0.3%, S&amp;P 500 futures and Dow futures were down 0.2%, while Russell 2000 futures fell 0.4%.On Stocktwits, however, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, remained ‘bullish’. While sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, has moved back to ‘bullish’ from ‘extremely bullish’ a day ago, amid high message volumes.<h2 class="st-heading-2">Trending Stocks To Watch</h2>Nvidia (NVDA): The Jensen Huang-led chipmaker is reportedly requiring full upfront payment, with&nbsp;no cancellation rights, for H200 chips from Chinese clients to hedge against regulatory export uncertainty. Microsoft (MSFT): The company’s communications&nbsp;chief took to social media to <a href="https://stocktwits.com/news-articles/markets/equity/microsoft-stock-in-focus-as-fresh-layoff-rumors-swirl/cmUGzFNR4PB">blast rumors</a> of fresh mass layoffs as "100% made up," attempting to steady the stock ahead of the&nbsp;market open. Apple (AAPL):&nbsp;Google parent Alphabet (GOOGL) surpassed Apple in market cap for the first time since 2019, closing at $3.888 trillion on Wednesday. It has also switched its banking partner from Goldman Sachs to JPMorgan, the new issuer of the Apple Card.&nbsp; Nio (NIO):&nbsp;The EV maker announced aggressive 2026 expansion plans for Australia, New Zealand, and Thailand, focusing on right-hand-drive markets to bypass Western tariffs. Applied Digital (APLD)&nbsp;saw a high volume of trading following its massive revenue growth report. Ventyx Biosciences (VTYX):&nbsp;Clear Street analyst downgraded the stock to ‘Hold’ from ‘Buy’ with a price target of $14, up from $11, after Eli Lilly (LLY) agreed to acquire Ventyx for $1.2B. Also, LifeSci Capital downgraded it to ‘Market Perform’ from ‘Outperform’ with a $14 price target.&nbsp; Alumis (ALMS) remains on retail radar following a massive ‘follow-on’ financing move following its recent clinical success. Alumis priced an&nbsp;upsized public offering of 17.65 million shares at&nbsp;$17 per share, aiming to raise&nbsp;$300 million. Elevai Labs (ELAB) popped 8%, and&nbsp;Omeros (OMER) rose 5% in after-hours trading on Wednesday, with Omeros gaining steam following a positive FDA conference call on its drug Yartemlea. U.S. defence stocks will be in focus, driven by&nbsp;Trump’s comments to bump up the military budget.Other noteworthy tickers trending on Stocktwits at the time of writing were&nbsp;One Stop Systems (OSS), Paramount Skydance (PSKY), IREN Limited (IREN), Momentus (MNTS), and Regencell Bioscience (RGC).Other Catalysts To Watch On the economic front, investors are looking ahead to the release of Initial Jobless Claims (8:30 a.m. ET), which is a crucial indicator ahead of Friday’s big employment report. Traders will also be monitoring the U.S. Trade Deficit &amp; Productivity data (8:30 a.m. ET) and Consumer Credit data (3 p.m. ET) later today.&nbsp; And noteworthy names on the earnings calendar today include Tilray Brands (TLRY), TD Synnex (SNX),&nbsp;Commercial Metals Company (CMC), and&nbsp;Neogen Corporation (NEOG), among others.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today

Nvidia, Apple, Microsoft, and select biotech names dominated early market buzz.

Traders work on the floor of the New York Stock Exchange during morning trading on December 10, 2025, in New York City, ahead of the Federal Reserve’s rate decision. 

Why Did ELAB Stock Surge Nearly 8% After-Hours Today?

After a not-so-great 2025, a push to buy a nuclear company has put PMGC Holdings back on investors’ radar.

Shares of PMGC Holdings Inc. jumped 230% in early premarket trading on Tuesday, drawing significant interest from Stocktwits members.Message volume for the ticker on Stocktwits rose a whopping 7,400% in the last 24 hours, and the sentiment reading shifted to 'extremely bullish' as of early Tuesday from 'bullish' the previous day.There was no apparent catalyst for the stock, although several users said they had the ticker on their watchlist.&nbsp;<figure class="image"><img style="aspect-ratio:571/79;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_14_at_1_17_11_PM_png_0063eedc3a.webp" alt="Screenshot 2025-10-14 at 1.17.11 PM.png" width="571" height="79"><figcaption>ELAB sentiment and message volume as of October 14 | Source: Stocktwits</figcaption></figure>PMGC Holdings, which changed its name from Elevai Labs Inc. and also redomiciled from Delaware to Nevada in December 2024, is a U.S.-based holding firm. The company, through its subsidiaries, focuses on cutting-edge aesthetic medicines and therapeutic products for skin aesthetics, obesity, and metabolic health.Its main product, EL-22, is an engineered probiotic designed to help prevent muscle loss during weight loss treatments, such as those using GLP-1 drugs.So far this year, PMGC has approached at least two companies — one manufacturing high-precision parts for the aerospace and defense sectors, and another packing solutions firm — for acquisitions.In August, the company implemented a one-for-3.5 reverse stock split of its common stock.Year-to-date,&nbsp;<a href="https://stocktwits.com/symbol/ELAB">ELAB shares</a> are down 90.7% on a split-adjusted basis. The company had a market cap of $3.5 million as of the stock's last close.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aka-stock-soars-over-40-after-hours/ch6mi41R3ls">AKA Stock Soars Over 40% After-Hours, Draws Interest From Retail Traders</a>

Traders work on the floor of the New York Stock Exchange during morning trading on September 17, 2025, in New York City. 

PMGC Holdings Stock Jumps 230% Premarket, Grabs Retail Eyeballs

Earlier known as Elevai Labs, PMGC turned into a holding company last year.

Shares of PMGC Holdings Inc. (ELAB) surged over 25% on Monday morning after the company inked a non-binding letter of intent to acquire a U.S. electronics contract manufacturing firm with a four-decade operational track record.This marks PMGC’s second acquisition initiative since April. The agreement pertains to a privately held firm specializing in high-accuracy electronics manufacturing.&nbsp;The target company’s capabilities include assembling electrical and mechanical components, producing printed circuit boards, conducting electronic component evaluations, and offering prototyping services.&nbsp;In 2024, the target company reported approximately $699,000 in revenue and an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of around $173,000.With this latest step, PMGC aims to expand its holdings by acquiring financially sound enterprises recognized for their reliable earnings and growth potential.&nbsp;PMGC executives noted that the acquisition target is distinguished by its efficient operations and long-standing partnerships within the commercial and industrial electronics markets.This acquisition aligns with a broader resurgence in U.S.-based manufacturing, fueled by government initiatives like the CHIPS and Science Act.&nbsp;Enacted on Aug. 9, 2022, the bipartisan CHIPS and Science Act seeks to revitalize the U.S. semiconductor sector while strengthening the country’s research and innovation ecosystem.&nbsp;The legislation allocates $52.7 billion in federal support to initiatives such as building new chip fabrication plants, advancing research and development efforts, and enhancing workforce training.&nbsp;As more supply chains shift back to domestic production, demand for American electronics manufacturers is on the rise.PMGC views this transaction as a timely opportunity to tap into that growing momentum.On Stocktwits, retail sentiment around PMGC changed to ‘extremely bullish’ from ‘bearish’ the previous day.<figure class="image"><img style="aspect-ratio:958/104;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_102350_png_3369427ecd.webp" alt="PMGC's Sentiment Meter and Message Volume as of 10:40 a.m. ET on Jun. 9, 2025 | Source: Stocktwits" width="958" height="104"><figcaption>PMGC's Sentiment Meter and Message Volume as of 10:40 a.m. ET on Jun. 9, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed optimism on the shares.<stembedurl>https://stocktwits.com/cjstocksup/message/617252666</stembedurl> <a href="https://stocktwits.com/symbol/ELAB">PMGC</a> stock has lost over 82% in 2025 and over 99% in the last 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/leddar-tech-extends-credit-and-loan-terms-welcomes-back-employees/chlEWXwRby9">LeddarTech Stock Jumps As Company Announces Amended Loan Terms: Retail Stays On The Sidelines</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure

PMGC views the transaction as a timely opportunity, as demand for American electronics manufacturers is on the rise, with more supply chains shifting back to domestic production.

Shares of PMGC Holdings Inc. (Elab) surged more than 50% on Friday as the skin care and biopharma products company said its subsidiary plans to present a probiotic-based weight loss treatment, sparking retail chatter.PMGC, formerly Elevai Labs, said its subsidiary Northstrive Biosciences was invited to present at an upcoming symposium called Anti-Obesity Treatments: Challenges and Emerging Solutions organized by UCLA Metabolism Theme, the company said.This symposium is targeted at obesity-focused clinicians, researchers, drug developers and investors to address the challenges brought up by weight loss treatments.Northstrive Biosciences’ EL-22 product is a probiotic approach for preserving muscle while on weight loss treatments, said the company. Northstrive’s EL-22 is being developed as a potential combination therapy with GLP-1 receptor agonists for preserving muscle while on weight loss treatments. According to studies, about 30-50% of body weight lost with GLP-1 based therapy is lean muscle mass, a common side effect.<stembedurl>https://stocktwits.com/DumbMoneyDoji/message/601529726</stembedurl><stembedurl>https://stocktwits.com/Schizoo/message/601513712</stembedurl>“The rise of anti-obesity medications has put the spotlight on the challenges being faced, particularly the management of muscle and bone loss associated with GLP-1 receptor agonists,” Orian Shirihai, Director of UCLA’s Metabolism Theme, said. “We organized this event to gather obesity’s leading opinion leaders to review the gaps and highlight the emerging solutions.”Last month, PMGC underwent a ‘strategic reorganization’ that included a name change to PMGC Holdings and redomiciling from Delaware to Nevada, in an effort to ‘streamline operations and create a more efficient legal and governance framework.”PMGC specializes in medical aesthetics and biopharmaceuticals with its subsidiaries across skincare, biosciences, research, among others.PMGC stock is up 35% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image. Source: Getty Images

PMGC Stock Surges On Invitation To Present ‘Probiotic’ For Preventing Muscle Loss: Retail Chatter Spikes

Its product, EL-22, is a probiotic approach for preserving muscle while on weight loss treatments

Shares of Elevai Labs Inc. ($ELAB) rose 8% on Friday after the operator of skin care product companies announced a ‘strategic reorganization’ including a name change to PMGC Holdings and redomiciling from Delaware to Nevada, drawing a mixed reaction from retail investors on Stocktwits. After this reorganization, Elevai, which specializes in medical aesthetics and biopharmaceuticals, will continue to trade on The Nasdaq Stock Market under the ticker symbol “ELAB.” The redomestication and name change will go into effect on Nasdaq at the opening of business on December 23, the company said.According to a company statement, the company will focus on enhancing operational efficiencies across its existing entities and pursue ‘synergistic acquisitions’ and also consider ‘strategic divestitures’ of assets that are underperforming or do not align with its long-term strategy. Its decision to redomicile from Delaware to Nevada aligns with its “mission to streamline operations and create a more efficient legal and governance framework,” it added, noting legal benefits such as a business-friendly regulatory environment and potential for long-term cost savings as a result of lower state tax obligations.Retail rection on Stocktwits was a mixed bag.<stembedurl>https://stocktwits.com/CatchingCrumbs/message/597432218</stembedurl><stembedurl>https://stocktwits.com/Chester_Copperpot85/message/597445584</stembedurl>Elavai’s portfolio consists of four wholly owned subsidiaries: Elevai Skincare Inc., Elevai Biosciences Inc., Elevai Research Inc., and PMGC Capital LLC.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Elevai Labs Announces Name Change to PMGC Holdings: Retail’s Cautious

After this reorganization, Elevai will continue to trade on The Nasdaq Stock Market under the ticker symbol “ELAB.”

The S&amp;P 500 retreated from its closing high (6,001.35) hit on Monday before ending the week at 5,870.62, down 2.08% for the 5-session period. Techs suffered steep losses, as evident from the 3.15% pullback by the Nasdaq Composite Index. The 30-stock Dow Jones Industrial Average was down a more modest 1.24%.As the rally stalled and the broader market experienced its steepest weekly losses since early September, the following stocks were the most active on the Stocktwits platform (based on message volume):<ul><li>Dogecoin (<a class="mention" data-mention="$DOGE.X" data-symbol-id="DOGE.X" href="https://stocktwits.com/symbol/DOGE.X" target="_blank">$DOGE.X</a>)</li><li>Bitcoin (<a class="mention" data-mention="$BTC.X" data-symbol-id="BTC.X" href="https://stocktwits.com/symbol/BTC.X" target="_blank">$BTC.X</a>)</li><li>Tesla, Inc. (<a class="mention" data-mention="$TSLA" data-symbol-id="TSLA" href="https://stocktwits.com/symbol/TSLA" target="_blank">$TSLA</a>)</li><li>Super Micro Computer, Inc. (<a class="mention" data-mention="$SMCI" data-symbol-id="SMCI" href="https://stocktwits.com/symbol/SMCI" target="_blank">$SMCI</a>)</li><li>Ripple (<a class="mention" data-mention="$XRP.X" data-symbol-id="XRP.X" href="https://stocktwits.com/symbol/XRP.X" target="_blank">$XRP.X</a>)</li><li>SPDR S&amp;P 500 ETF Trust (<a class="mention" data-mention="$SPY" data-symbol-id="SPY" href="https://stocktwits.com/symbol/SPY" target="_blank">$SPY</a>)</li><li>Autozi Internet Technology Global Ltd. (<a class="mention" data-mention="$AZI" data-symbol-id="AZI" href="https://stocktwits.com/symbol/AZI" target="_blank">$AZI</a>)</li><li>Trump Media &amp; Technology Group Corp. (<a class="mention" data-mention="$DJT" data-symbol-id="DJT" href="https://stocktwits.com/symbol/DJT" target="_blank">$DJT</a>)</li><li>GameStop Corp. (<a class="mention" data-mention="$GME" data-symbol-id="GME" href="https://stocktwits.com/symbol/GME" target="_blank">$GME</a>)</li><li>Elevai Labs, Inc. (<a class="mention" data-mention="$ELAB" data-symbol-id="ELAB" href="https://stocktwits.com/symbol/ELAB" target="_blank">$ELAB</a>)</li></ul>Dogecoin: Riding on the crypto rally following Donald Trump’s victory in the 2024 presidential election, Dogecoin rallied to a high of $0.435863 on Tuesday pulling back to a low of $0.354469 three sessions later.&nbsp;A poll&nbsp; to solicit opinion from Stocktwits users regarding the year-end price target for Doge, which has an hour left for closing, showed about 41% think it would end 2024 between $0.50 and $1.00.&nbsp;A Stocktwits user said the rally could resume if rumors of the incoming Trump administration eliminate capital gains taxes on U.S.-issued cryptocurrencies.&nbsp;<stembedurl>https://stocktwits.com/Gainz4dayss/message/592967020</stembedurl>Bitcoin:&nbsp;Bitcoin, which is the top crypto by market capitalization, broke above $80K last Sunday and climbed to an intraday high of $93,434.35 on Wednesday. Since then, the Bitcoin rally has cooled off amid the stock market weakness.&nbsp;Bullish investors and analysts are eyeing a break above the $100,000 mark.&nbsp;Stocktwits users are mostly positive, with one user suggesting the technical chart looks “pretty solid.”<stembedurl>https://stocktwits.com/MainlyAlright/message/592966996</stembedurl>Tesla:&nbsp;The extended rally in the shares of Elon Musk-led electric-vehicle company Tesla stalled last week. After scaling an intraday high of $358.64 and a closing high of $350 on Monday, the stock has pulled back sharply. For the week, Tesla shares lost 0.16%, although they shed a steeper 10.57% from the intraday highs.&nbsp;Tesla bull and the Future Fund LLC Managing Partner Gary Black recently trimmed his Tesla position, reasoning that Tesla at $350 is less attractive than Tesla at $140.Super Micro: Embattled artificial intelligence server maker Super Micro fell in the first four sessions of the week amid fears of potential delisting. The company delayed the filing of its annual report for the fiscal year 2024 and also its first quarter of the next fiscal that ended on Sept. 30, 2024.&nbsp;The company received some good tidings late in the week when three broker-dealers with common ownership acquired 30.83 million shares of the company, translating to a 5.3% stake.The unfolding week is important as investors await word on the company’s response to the deadline for filing its annual report.Ripple: Payments cryptocurrency XRP crossed the $1 threshold on Saturday for the first time in three years. The crypto’s strength is attributable to the expectations that the incoming Trump administration will formulate pro-crypto policies.&nbsp;Ripple has been the subject of an investigation by the SEC after the blockchain company raised more than $1.3 billion in 2013 by selling XRP in an unregistered public offering. The SEC has an ongoing lawsuit against Ripple in the U.S.&nbsp;Southern District Court of New York.The widespread expectation is that SEC Chair Gary Gensler, who has been tough with cryptocurrency companies, could step down soon as part of the new guard taking over on the political arena.&nbsp;SPY:&nbsp;Following the market pullback, SPY garnered some attention and was among the active sought out security on Stocktwits last week. The upcoming week is crucial for the SPY, as Nvidia - a heavily weighted stock, is scheduled to report earnings. The artificial intelligence stalwart’s earnings have ramifications for a slew of heavily-weighted tech stocks pursuing AI.&nbsp;Some key economic data due for the unfolding week include S&amp;P Global’s private sector activity readings for November, the Conference Board’s leading economic index for October, the weekly jobless claims data and a few housing market readings. The market participants may also stay tuned to a spate of Fed speeches scheduled for they week as they worry about the rate trajectory.Autozi:&nbsp;Chinese automotive products and services company Autozi was in the news last week amid news of increased institutional interest in the company. Message volume for the stock spiked higher, with most on Stocktwits ‘bullish’ on the stock.&nbsp;The company followed up with the two 13G filings on Wednesday, and filed yet another on Friday in which it disclosed CEO&nbsp;Houqi Zhang has hiked his stake to 40.6% of the Class A shares, assuming conversion of the Class B ordinary shares owned by him.&nbsp;Trump Media: The post-election bump received by Trump-controlled Trump Media &amp; Technology stock cooled off last week. The owner of Truth Social platform continues to be viewed positively by the retail.&nbsp;GameStop:&nbsp;Meme stock GameStop, a retailer of video games, saw volatility in the week ended Nov. 15. It, however, bucked the broader market weakness and ended the week up by 6.87%.&nbsp;Elevai Labs:&nbsp;Newport Beach, California-based Elevai, a skincare development company, was in the news over the release of its fiscal year second-quarter results last week. Retailers on Stockwits are hoping for a short-squeeze, with 19.08% of the outstanding shares held short.&nbsp;Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/trip.com-earnings-for-q3-2024-due-after-the-market-close-monday/cJ4HsezRQ2">Trip.com Analysts Optimistic Amid Robust Travel Trends In China As Stock Looks To Extend Strong Gains For Year</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

The broader market pulled back last week amid a few strong data and hawkish Fed commentary. | Photo Courtesy of Wikimedia Commons

10 Most Active Stocks On Stocktwits Last Week With Message Volume Spurt 

Cryptocurrencies, stocks that pulled back from their post-election highs, and some obscure securities were among those that saw huge message volumes in the past week.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

ELAB
PMGC Holdings Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ELAB News

ELABPMGC Holdings Inc.